253 related articles for article (PubMed ID: 35008709)
1. CRISPR/Cas9 Genome Editing vs. Over-Expression for Fluorescent Extracellular Vesicle-Labeling: A Quantitative Analysis.
Strohmeier K; Hofmann M; Hauser F; Sivun D; Puthukodan S; Karner A; Sandner G; Le Renard PE; Jacak J; Mairhofer M
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008709
[TBL] [Abstract][Full Text] [Related]
2. Engineered Cas9 extracellular vesicles as a novel gene editing tool.
Osteikoetxea X; Silva A; Lázaro-Ibáñez E; Salmond N; Shatnyeva O; Stein J; Schick J; Wren S; Lindgren J; Firth M; Madsen A; Mayr LM; Overman R; Davies R; Dekker N
J Extracell Vesicles; 2022 May; 11(5):e12225. PubMed ID: 35585651
[TBL] [Abstract][Full Text] [Related]
3. Reporter mice for isolating and auditing cell type-specific extracellular vesicles in vivo.
McCann JV; Bischoff SR; Zhang Y; Cowley DO; Sanchez-Gonzalez V; Daaboul GD; Dudley AC
Genesis; 2020 Jul; 58(7):e23369. PubMed ID: 32543746
[TBL] [Abstract][Full Text] [Related]
4. Engineered extracellular vesicles as versatile ribonucleoprotein delivery vehicles for efficient and safe CRISPR genome editing.
Yao X; Lyu P; Yoo K; Yadav MK; Singh R; Atala A; Lu B
J Extracell Vesicles; 2021 Mar; 10(5):e12076. PubMed ID: 33747370
[TBL] [Abstract][Full Text] [Related]
5. Encapsulating Cas9 into extracellular vesicles by protein myristoylation.
Whitley JA; Kim S; Lou L; Ye C; Alsaidan OA; Sulejmani E; Cai J; Desrochers EG; Beharry Z; Rickman CB; Klingeborn M; Liu Y; Xie ZR; Cai H
J Extracell Vesicles; 2022 Apr; 11(4):e12196. PubMed ID: 35384352
[TBL] [Abstract][Full Text] [Related]
6. Improved CRISPR/Cas9 gene editing by fluorescence activated cell sorting of green fluorescence protein tagged protoplasts.
Petersen BL; Möller SR; Mravec J; Jørgensen B; Christensen M; Liu Y; Wandall HH; Bennett EP; Yang Z
BMC Biotechnol; 2019 Jun; 19(1):36. PubMed ID: 31208390
[TBL] [Abstract][Full Text] [Related]
7.
Ye Y; Shi Q; Yang T; Xie F; Zhang X; Xu B; Fang J; Chen J; Zhang Y; Li J
Technol Cancer Res Treat; 2022; 21():15330338221085370. PubMed ID: 35315725
[No Abstract] [Full Text] [Related]
8. Preparation of NanoMEDIC Extracellular Vesicles to Deliver CRISPR-Cas9 Ribonucleoproteins for Genomic Exon Skipping.
Watanabe K; Gee P; Hotta A
Methods Mol Biol; 2023; 2587():427-453. PubMed ID: 36401042
[TBL] [Abstract][Full Text] [Related]
9. Tropism-facilitated delivery of CRISPR/Cas9 system with chimeric antigen receptor-extracellular vesicles against B-cell malignancies.
Xu Q; Zhang Z; Zhao L; Qin Y; Cai H; Geng Z; Zhu X; Zhang W; Zhang Y; Tan J; Wang J; Zhou J
J Control Release; 2020 Oct; 326():455-467. PubMed ID: 32711027
[TBL] [Abstract][Full Text] [Related]
10. Quantification of protein cargo loading into engineered extracellular vesicles at single-vesicle and single-molecule resolution.
Silva AM; Lázaro-Ibáñez E; Gunnarsson A; Dhande A; Daaboul G; Peacock B; Osteikoetxea X; Salmond N; Friis KP; Shatnyeva O; Dekker N
J Extracell Vesicles; 2021 Aug; 10(10):e12130. PubMed ID: 34377376
[TBL] [Abstract][Full Text] [Related]
11. Delivery of an Artificial Transcription Regulator dCas9-VPR by Extracellular Vesicles for Therapeutic Gene Activation.
Lainšček D; Kadunc L; Keber MM; Bratkovič IH; Romih R; Jerala R
ACS Synth Biol; 2018 Dec; 7(12):2715-2725. PubMed ID: 30513193
[TBL] [Abstract][Full Text] [Related]
12. Spatial and Temporal Control of CRISPR-Cas9-Mediated Gene Editing Delivered via a Light-Triggered Liposome System.
Aksoy YA; Yang B; Chen W; Hung T; Kuchel RP; Zammit NW; Grey ST; Goldys EM; Deng W
ACS Appl Mater Interfaces; 2020 Nov; 12(47):52433-52444. PubMed ID: 33174413
[TBL] [Abstract][Full Text] [Related]
13. Exosomes as Targeted Delivery Platform of CRISPR/Cas9 for Therapeutic Genome Editing.
Duan L; Ouyang K; Wang J; Xu L; Xu X; Wen C; Xie Y; Liang Y; Xia J
Chembiochem; 2021 Dec; 22(24):3360-3368. PubMed ID: 34418266
[TBL] [Abstract][Full Text] [Related]
14. Extracellular vesicles engineered with valency-controlled DNA nanostructures deliver CRISPR/Cas9 system for gene therapy.
Zhuang J; Tan J; Wu C; Zhang J; Liu T; Fan C; Li J; Zhang Y
Nucleic Acids Res; 2020 Sep; 48(16):8870-8882. PubMed ID: 32810272
[TBL] [Abstract][Full Text] [Related]
15. Engineering extracellular vesicles to deliver CRISPR ribonucleoprotein for gene editing.
Whitley JA; Cai H
J Extracell Vesicles; 2023 Sep; 12(9):e12343. PubMed ID: 37723839
[TBL] [Abstract][Full Text] [Related]
16. Purification Analysis, Intracellular Tracking, and Colocalization of Extracellular Vesicles Using Atomic Force and 3D Single-Molecule Localization Microscopy.
Puthukodan S; Hofmann M; Mairhofer M; Janout H; Schurr J; Hauser F; Naderer C; Preiner J; Winkler S; Sivun D; Jacak J
Anal Chem; 2023 Apr; 95(14):6061-6070. PubMed ID: 37002540
[TBL] [Abstract][Full Text] [Related]
17. One-step generation of triple knockout CHO cell lines using CRISPR/Cas9 and fluorescent enrichment.
Grav LM; Lee JS; Gerling S; Kallehauge TB; Hansen AH; Kol S; Lee GM; Pedersen LE; Kildegaard HF
Biotechnol J; 2015 Sep; 10(9):1446-56. PubMed ID: 25864574
[TBL] [Abstract][Full Text] [Related]
18. Genetic labeling of extracellular vesicles for studying biogenesis and uptake in living mammalian cells.
Levy D; Do MA; Brown A; Asano K; Diebold D; Chen H; Zhang J; Lawler B; Lu B
Methods Enzymol; 2020; 645():1-14. PubMed ID: 33565965
[TBL] [Abstract][Full Text] [Related]
19. Autophagy inhibitors enhance biomolecular delivery efficiency of extracellular vesicles.
Zhang Y; Huang M; Jiang L; Li T; Wang J; Zhao L; Zhou J
Biochem Biophys Res Commun; 2022 May; 603():130-137. PubMed ID: 35287054
[TBL] [Abstract][Full Text] [Related]
20. Recent Advances in CRISPR/Cas9 Delivery Strategies.
Yip BH
Biomolecules; 2020 May; 10(6):. PubMed ID: 32486234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
